<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03708029</url>
  </required_header>
  <id_info>
    <org_study_id>SLRV-POD-WC-001</org_study_id>
    <nct_id>NCT03708029</nct_id>
  </id_info>
  <brief_title>Efficacy of Human Placental Graft in Diabetic Foot Ulcers</brief_title>
  <official_title>A Clinical Investigation Into the Efficacy of Full-thickness Human Placental Graft (Revita) in Diabetic Foot Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>StimLabs</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>StimLabs</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the efficacy of full-thickness placental allograft in chronic wound healing
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the efficacy of Revita full thickness placental allograft in improving wound
      closure rates and mean closure time in diabetic foot ulcers (DFUs) as compared to the current
      standards of wound care treatment
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 13, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete Wound Closure</measure>
    <time_frame>12 weeks</time_frame>
    <description>100% epithelization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent(%) Healed</measure>
    <time_frame>12 weeks</time_frame>
    <description>Percentage of wound healed</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Diabetic Foot</condition>
  <arm_group>
    <arm_group_label>Intervention Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Will receive Revita allograft for wound treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Will receive current standard of care for wound treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Revita Allograft</intervention_name>
    <description>Human placental allograft</description>
    <arm_group_label>Intervention Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female patients

          -  18-80 years old

          -  Diagnosis of Type 1 or 2 Diabetes Mellitus

          -  Foot ulcers &gt;1cm2 and &lt;25cm2 for 4 weeks or more prior to enrollment

          -  Able to give consent to participate

          -  Compliance with all aspects of protocol and follow-up

        Exclusion Criteria:

          -  Male and female patients younger than 18 years old

          -  Male or female patients older than 80 years old

          -  Smoking, and any additional health risk factors contraindicated with Revita use

          -  Involvement in any other ongoing studies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Research Manager</last_name>
    <role>Study Director</role>
    <affiliation>StimLabs</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Clinical Research Manager</last_name>
    <phone>4706160997</phone>
    <email>bwilliams@stimlabs.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>VP Clinical Development</last_name>
    <email>chas@stimlabs.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gulf Coast Podiatry</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Kiefer, DPM</last_name>
    </contact>
    <investigator>
      <last_name>Joseph Kiefer, DPM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Louisiana Foot and Ankle Specialists</name>
      <address>
        <city>Lake Charles</city>
        <state>Louisiana</state>
        <zip>70605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Hall, DPM</last_name>
    </contact>
    <investigator>
      <last_name>Daniel Hall, DPM</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mallory Przybylski, DPM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Springfield Hospital - Center for Wound Healing</name>
      <address>
        <city>Springfield</city>
        <state>Pennsylvania</state>
        <zip>19064</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris Barrett, DPM</last_name>
    </contact>
    <investigator>
      <last_name>Chris Barrett, DPM</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sneha Patel, DPM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>October 12, 2018</study_first_submitted>
  <study_first_submitted_qc>October 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 16, 2018</study_first_posted>
  <last_update_submitted>November 13, 2018</last_update_submitted>
  <last_update_submitted_qc>November 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

